[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100482734":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":26,"responsibleParty":53,"collaborators":10,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"University Hospital, Tours","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"patients with vascularitis",null,"Two additional 7ml EDTA tubes of blood are taken from the same blood puncture as during routine follow-up at several points in the follow-up",[13],"Other: Sampling",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Sampling","4 blood sampling per patient and an additional one in case of relapse",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":24,"email":25},"Alexandra Audemard verger","CONTACT","02 47 47 37 15","+33","alexandra.audemardverger@univ-tours.fr",[27],{"facility":28,"status":29,"city":30,"state":10,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"University hospital","RECRUITING","Tours","37044","France","FR",{"type":35,"coordinates":36},"Point",[37,38],0.70398,47.39484,{"lat":38,"lon":37},[41,44,47,49,51],{"name":42,"role":22,"phone":43,"phoneExt":24,"email":25},"Alexandra Audemard Verger","0247473715",{"name":45,"role":46,"phone":10,"phoneExt":10,"email":10},"Jean Michel HALIMI","SUB_INVESTIGATOR",{"name":48,"role":46,"phone":10,"phoneExt":10,"email":10},"Laurent MACHET",{"name":50,"role":46,"phone":10,"phoneExt":10,"email":10},"Isabelle GRIFFOUL",{"name":52,"role":46,"phone":10,"phoneExt":10,"email":10},"François MAILLOT",{"type":54,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100482734","search-for-bio-diagnostic-and-prognostic-markers-in-adult-vascularitis-100482734",false,"NCT05565885","Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis","BIOVAS","Inclusion Criteria:\n\n* Age \\> 16 years\n* Active vasculitis, new diagnosis or relapse\n* IgA vasculitis\n* ANCA vasculitis\n* Giant cell arteritis\n\nExclusion Criteria:\n\n* Person who has objected to the processing of data\n* Pregnant woman\n* Patient positive for HIV, HBV, HCV\n* Treatment in the previous month with corticosteroids, immunosuppressive drugs or biotherapy.\n* Patient unable to understand the information leaflet\n* Adult under guardianship or curatorship","ALL","16 Years",{"count":65,"type":66},225,"ESTIMATED","OBSERVATIONAL","To date, there are no reliable diagnostic blood markers of adult vasculitis. To date, the diagnosis of vasculitis is based on invasive procedure, biopsy of affected tissues potentially at risk of complication . In addition, there are no reliable biomarkers to predict the evolution of vasculitis (relapse, refractory form ...) necessary for the management of patients (type of treatment, duration ..)\n\nProspective study, monocentric (CHU de Tours), non-interventional, aimed at finding diagnostic and prognostic biomarkers (both metabolomic and immunologic) in adult vasculitis patients.",[70],"Vasculitis",[72,73,74],"biomarkers","diagnosis","prognosis","2025-05-22",{"date":77,"type":78},"2025-05-29","ACTUAL",{"date":80,"type":78},"2022-11-22",{"date":82,"type":66},"2037-12",{"name":5,"class":6},1]